Anna Beck

Position title: Assistant Professor



  • MD, Loyola University Chicago Stritch School of Medicine, Chicago, IL
  • General Surgery Residency, University of Iowa, Iowa City, IA
  • Fellowship, Breast Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
  • T32 Research Fellowship, Surgical Oncology, University of Iowa, Iowa City, IA

Clinical Specialties

Dr. Beck specializes in breast surgical oncology with a focus on benign and malignant breast disease, including breast cancer, benign breast disease, high risk breast lesions, and patients at high risk for developing breast cancer. She is certified by the American Board of Surgery.

Research Interests

Dr. Beck’s principal research interests are in breast cancer genomics, specifically seeking to better understand breast cancer risk with the aim of developing ways to better identify individuals who are high risk for the development of breast cancer. She is a member of the Center for Human Genomics and Precision Medicine at UW.

Recent Publications

  • ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
    Tran A, Weigel RJ, Beck AC
    Am J Surg 2023 Nov 02;
    [PubMed ID: 37968147]
  • Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
    Beck AC, Bayard S, Plitas G, Sevilimedu V, Kuba MG, Garcia P, Morrow M, Tadros AB
    Ann Surg Oncol 2023 Oct; 30(10): 6061-6069
    [PubMed ID: 37493892]
  • Axillary lymph node dissection: Dead or still alive?
    Beck AC, Morrow M
    Breast 2023 Jun; 69: 469-475
    [PubMed ID: 36702672]
  • A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.
    Spanheimer PM, Bashir A, Lorenzen AW, Beck AC, Liao J, Lizarraga IM, Erdahl LM, Sugg SL, Karwal MW, Weigel RJ
    Am J Clin Oncol 2021 Sep 01; 44(9): 456-462
    [PubMed ID: 34190716]
  • Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
    Beck AC, Rajan A, Landers S, Kelley S, Bellizzi AM, Lal G, Sugg SL, Howe JR, Chan CH, Weigel RJ
    Surgery 2022 Jan; 171(1): 245-251
    [PubMed ID: 34362588]

All Publications on PubMed